Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Na ïve Metastatic Uveal Melanoma
Condition: Melanoma, Uveal Interventions: Drug: Pembrolizumab; Drug: Lenvatinib Sponsors: Providence Health & Services; Merck Sharp & Dohme Corp.; Eisai Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials